AGC Inc. (TYO:5201) is looking to invest more than 200 billion yen ($1.7 billion) into CDMO operations by 2025. Plans…...
Please subscribe to read the full story.
gene therapy
Astellas to Acquire US Gene Therapy Venture Audentes
Astellas Pharma Inc. (TYO:4503) recently announced that it has agreed to acquire Audentes Therapeutics Inc., a U.S.-based venture specializing in…...
Please subscribe to read the full story.
Ajinomoto Makes Moves With Advanced Products in Biopharma Sector
Ajinomoto Co. Inc. (TYO:2802) is positioning cutting-edge operations as a driver of future business growth for its contract manufacturing of…...
Please subscribe to read the full story.
